Skip to content
Disclosery

TRV GP VI, LLC

Follow

13F filer, CIK 1990716, Boston, MA

TRV GP VI, LLC reported $135,595,117 across 3 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-07.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-212009

Period
2026-03-31
Reported value
$136M
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001193125-26-212009, largest first. % of portfolio is the value over $135,595,117, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 3,152,456 shares; 2025Q1: 4,211,659 shares; 2025Q2: 4,211,659 shares; 2025Q3: 4,211,659 shares; 2025Q4: 4,211,659 shares; 2026Q1: 4,211,659 shares 4,211,659$101M74.64%0Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 969,218 shares; 2025Q1: 969,218 shares; 2025Q2: 969,218 shares; 2025Q3: 969,218 shares; 2025Q4: 969,218 shares; 2026Q1: 969,218 shares 969,218$30.3M22.37%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 194,174 shares; 2025Q1: 194,174 shares; 2025Q2: 194,174 shares; 2025Q3: 194,174 shares; 2025Q4: 194,174 shares; 2026Q1: 194,174 shares 194,174$4.06M3%0Timeline

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-212009 base2026-05-07acceptance time not in the bulk data set